Prof. Ravi Prakash Mahajan CBE

Director, Critical Care Integration and Transformation, Apollo Hospitals Group, India

Director, Research and Innovation, Apollo Hospitals Group, India

Professor Emeritus, University of Nottingham, UK

Apollo Hospitals

Professor Ravi is a leader in UK Anaesthesia and Intensive Care, more recently as President, Royal College of Anaesthetists. His important international portfolios include Editor in Chief of the British Journal of Anaesthesia (2012-2016); Council member, Royal College of Anaesthetists (RCoA) since 2007; Chairman Safety and Quality Committee, European Society of Anaesthesiology (2012-2016); Chairman, Ethics Committee, Nottingham University (2016-2019); Vice President, Royal College of Anaesthetists (2016-2018) and Medicolegal and Ethics Expert for the court of law in the UK.

He has well over 200 Peer-Reviewed International Publications, and has co-authored five textbooks, with his most recent work on Death, Religion and Law (

He has successfully established and led a number of international networks and organizations. These include Safe Anaesthesia Liaison Group (Founding Chairman SALG;; Safety Committee of European Society of Anesthesiology; National Institute of Academic Anaesthesia (Founding Board Member and Chairman NIAA;; and very recently the Centre for Perioperative Care (CPOC and International Academy of the Colleges of Anaesthesiology.

Professor Ravi's services to the field of medicine, with a long track record of International Leadership in improving patient care through Professional Standards, Quality Improvement, Education and Research, were recognised recently with the award of CBE (Commander of the order of British Empire) in 2022 Queen’s New Years Honour List of Great Britain and Commonwealth.

In his current positions at Apollo Hospitals Group, he has led the introduction and implementation of comprehensive connected care, a pioneering transformational program for health care delivery in India. He is responsible for bringing in innovative transformational initiatives which require extensive stakeholder engagement alongside interface between technology and medicine, and overseeing international projects from conception to complete roll-out. In addition, he is responsible for overseeing all the aspects related to Research and Innovation.